DR
Devarapalli Rajasekhar Reddy
About Devarapalli Rajasekhar Reddy
Data last updated:
Devarapalli Rajasekhar Reddy is a Director at Lippincotts Pharmaceuticals Private Limited (since 2024) and Director at Lippin Healthcare Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Lippincotts Pharmaceuticals Private Limited at ₹1.19 Cr (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Oct 2024 | 2017 | ₹1.19 Cr (FY 2020) | Active | |
| Director | 29 Dec 2025 | 2025 | Active |
Board colleagues of Devarapalli Rajasekhar Reddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Samba Siva Rao Vulleru | 07726210 | Lippincotts Pharmaceuticals Private Limited , Lippin Healthcare Private Limited | Director |
| Venkatasubbaiah Pujala | 07726275 | Lippincotts Pharmaceuticals Private Limited , Lippin Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Devarapalli Rajasekhar Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devarapalli Rajasekhar Reddy
Devarapalli Rajasekhar Reddy currently holds 2 directorships: Lippincotts Pharmaceuticals Private Limited (Director, since 21 Oct 2024, revenue ₹1.19 Cr (FY 2020)); Lippin Healthcare Private Limited (Director, since 29 Dec 2025).
Devarapalli Rajasekhar Reddy was first appointed on 21 Oct 2024 as Director at Lippincotts Pharmaceuticals Private Limited. The most recent appointment on record is 29 Dec 2025 at Lippin Healthcare Private Limited.
The current boards of Devarapalli Rajasekhar Reddy's companies include Samba Siva Rao Vulleru (Lippincotts Pharmaceuticals Private Limited), Venkatasubbaiah Pujala (Lippincotts Pharmaceuticals Private Limited).